{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:21:24Z","timestamp":1792002084043,"version":"4.4.0"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>ATP13A2 is a lysosomal protein involved in polyamine transport with loss of function mutations associated with multiple neurodegenerative conditions. These include early onset Parkinson\u2019s disease, Kufor-Rakeb Syndrome, neuronal ceroid lipofuscinosis, hereditary spastic paraplegia, and amyotrophic lateral sclerosis. While <jats:italic>ATP13A2<\/jats:italic> mutations may result in clinical heterogeneity, the basal ganglia appear to be impacted in the majority of cases. The basal ganglia is particularly vulnerable to environmental exposures such as heavy metals, pesticides, and industrial agents which are also established risk factors for many neurodegenerative conditions. Not surprisingly then, impaired function of ATP13A2 has been linked to heavy metal toxicity including manganese, iron, and zinc. This review discusses the role of ATP13A2 in basal ganglia function and dysfunction, potential common pathological mechanisms in ATP13A2-related disorders, and how gene x environment interactions may contribute to basal ganglia dysfunction.<\/jats:p>","DOI":"10.3389\/fneur.2023.1252400","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:18:28Z","timestamp":1704428308000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["ATP13A2 (PARK9) and basal ganglia function"],"prefix":"10.3389","volume":"14","author":[{"given":"Kristina M.","family":"Croucher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila M.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1093\/hmg\/dds089","article-title":"Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis","volume":"21","author":"Bras","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.1002\/mgg3.1052","article-title":"Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype","volume":"8","author":"Estiar","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/brain\/aww307","article-title":"Loss-of-function mutations in the ATP13A2\/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)","volume":"140","author":"Estrada-Cuzcano","year":"2017","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/brain\/aww111","article-title":"Genetic and phenotypic characterization of complex hereditary spastic paraplegia","volume":"139","author":"Kara","year":"2016","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited \u03b1-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40246-019-0203-9","article-title":"Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion","volume":"13","author":"Spataro","year":"2019","journal-title":"Hum Genomics"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"ddw348","DOI":"10.1093\/hmg\/ddw348","article-title":"Additional rare variant analysis in Parkinson\u2019s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance","volume":"25","author":"Lubbe","year":"2016","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2051-5960-1-11","article-title":"ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies","volume":"1","author":"Murphy","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.nbd.2020.104786","article-title":"Dysregulated iron metabolism in C. elegans catp-6\/ATP13A2 mutant impairs mitochondrial function","volume":"139","author":"Anand","year":"2020","journal-title":"Neurobiol Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jtemb.2019.05.005","article-title":"Zn homeostasis in genetic models of Parkinson\u2019s disease in Caenorhabditis elegans","volume":"55","author":"Baesler","year":"2019","journal-title":"J Trace Elem Med Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1002\/jnr.23112","article-title":"Characterization of cellular protective effects of ATP13A2\/PARK9 expression and alterations resulting from pathogenic mutants","volume":"90","author":"Covy","year":"2012","journal-title":"J Neurosci Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2014.10.007","article-title":"\u03b1-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson\u2019s disease occurs independent of ATP13A2 (PARK9)","volume":"73","author":"Daniel","year":"2015","journal-title":"Neurobiol Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuro.2017.06.005","article-title":"The effect of manganese exposure in Atp13a2-deficient mice","volume":"64","author":"Fleming","year":"2018","journal-title":"Neurotoxicology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ng.300","article-title":"Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","volume":"41","author":"Gitler","year":"2009","journal-title":"Nat Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1093\/hmg\/ddu099","article-title":"Parkinson\u2019s disease-linked human PARK9\/ATP13A2 maintains zinc homeostasis and promotes \u03b1-Synuclein externalization via exosomes","volume":"23","author":"Kong","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/hmg\/ddt623","article-title":"Parkinson\u2019s disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction","volume":"23","author":"Park","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1523\/JNEUROSCI.3117-15.2016","article-title":"Regulation of ATP13A2 via PHD2-HIF1\u03b1 signaling is critical for cellular iron homeostasis: implications for Parkinson\u2019s disease","volume":"36","author":"Rajagopalan","year":"2016","journal-title":"J Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbamem.2015.04.008","article-title":"The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity","volume":"1848","author":"Rinaldi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbrc.2009.03.151","article-title":"Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2","volume":"383","author":"Schmidt","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"29654","DOI":"10.1074\/jbc.M111.233874","article-title":"Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein","volume":"286","author":"Tan","year":"2011","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1093\/hmg\/ddt572","article-title":"Zn2+ dyshomeostasis caused by loss of ATP13A2\/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation","volume":"23","author":"Tsunemi","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e0220849","DOI":"10.1371\/journal.pone.0220849","article-title":"Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity","volume":"14","author":"Ugolino","year":"2019","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/mds.22996","article-title":"Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations","volume":"25","author":"Behrens","year":"2010","journal-title":"Mov Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archneurol.2010.281","article-title":"Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype","volume":"67","author":"Br\u00fcggemann","year":"2010","journal-title":"Arch Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ajmg.b.31214","article-title":"ATP13A2 variability in Taiwanese Parkinson\u2019s disease","author":"Chen","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease","volume":"68","author":"Di Fonzo","year":"2007","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/mds.22728","article-title":"ATP13A2 variants in early-onset Parkinson\u2019s disease patients and controls","volume":"24","author":"Djarmati","year":"2009","journal-title":"Mov Disord"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1399-0004.2011.01745.x","article-title":"Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9)","volume":"82","author":"Eiberg","year":"2012","journal-title":"Clin Genet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1600-0404.1994.tb02645.x","article-title":"Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome","volume":"89","author":"Najimal-Din","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/mds.22947","article-title":"ATP13A2 mutations (PARK9) cause neurodegeneration with brain Iron accumulation","volume":"25","author":"Schneider","year":"2010","journal-title":"Mov Disord"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.20511","article-title":"Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia","volume":"20","author":"Williams","year":"2005","journal-title":"Mov Disord"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pneurobio.2018.07.003","article-title":"Selective basal ganglia vulnerability to energy deprivation: experimental and clinical evidences","volume":"169","author":"Tambasco","year":"2018","journal-title":"Prog Neurobiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1212\/WNL.0000000000012705","article-title":"Neuropathologic findings in a patient with juvenile-onset levodopa-responsive parkinsonism due to ATP13A2 mutation","volume":"97","author":"Chien","year":"2021","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/jmg.38.10.680","article-title":"Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36","volume":"38","author":"Hampshire","year":"2001","journal-title":"J Med Genet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jocn.2012.05.052","article-title":"The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson\u2019s disease","volume":"20","author":"Chan","year":"2013","journal-title":"J Clin Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neulet.2010.03.018","article-title":"Lack of association between ATP13A2 Ala746Thr variant and Parkinson\u2019s disease in Han population of mainland China","volume":"475","author":"Fei","year":"2010","journal-title":"Neurosci Lett"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1002\/mds.23106","article-title":"Rapid screening of ATP13A2 variant with high-resolution melting analysis","volume":"25","author":"Funayama","year":"2010","journal-title":"Mov Disord"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.12659\/MSM.892821","article-title":"Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson\u2019s disease patients in Xinjiang Uygur and Han ethnic groups","volume":"20","author":"Li","year":"2014","journal-title":"Med Sci Monit"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1212\/01.wnl.0000335167.72412.68","article-title":"Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore","volume":"71","author":"Lin","year":"2008","journal-title":"Neurology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"6954820","DOI":"10.1155\/2020\/6954820","article-title":"ATP13A2 gene variants in patients with Parkinson\u2019s disease in Xinjiang","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res Int"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.parkreldis.2010.10.011","article-title":"Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation","volume":"17","author":"Crosiers","year":"2011","journal-title":"Parkinsonism Relat Disord."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ejpn.2011.01.001","article-title":"Juvenile parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation","volume":"15","author":"Fong","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"371256","DOI":"10.1155\/2014\/371256","article-title":"Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review","volume":"2014","author":"Yang","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.nbd.2011.02.009","article-title":"A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers","volume":"42","author":"Farias","year":"2011","journal-title":"Neurobiol Dis"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e1002304","DOI":"10.1371\/journal.pgen.1002304","article-title":"A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier","volume":"7","author":"W\u00f6hlke","year":"2011","journal-title":"PLoS Genet"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/genes13081306","article-title":"Frequency of Parkinson\u2019s disease genes and role of PARK2 in amyotrophic lateral sclerosis: an NGS study","volume":"13","author":"Vacchiano","year":"2022","journal-title":"Genes"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/cimb45040217","article-title":"Role of oxidative stress on the etiology and pathophysiology of amyotrophic lateral sclerosis (ALS) and its relation with the enteric nervous system","volume":"45","author":"L\u00f3pez-Pingarr\u00f3n","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.bbrc.2004.08.156","article-title":"Characterization of the P5 subfamily of P-type transport ATPases in mice","volume":"323","author":"Schultheis","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/humu.21527","article-title":"Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism","volume":"32","author":"Park","year":"2011","journal-title":"Hum Mutat"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1093\/hmg\/ddr274","article-title":"Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death","volume":"20","author":"Ugolino","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"9040","DOI":"10.1073\/pnas.1508220112","article-title":"A lipid switch unlocks Parkinson\u2019s disease-associated ATP13A2","volume":"112","author":"Holemans","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.bbabio.2010.04.010","article-title":"Structural divergence between the two subgroups of P5 ATPases","volume":"1797","author":"S\u00f8rensen","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"C1279","DOI":"10.1152\/ajpcell.1997.272.4.C1279","article-title":"Phospholipase D activity facilitates Ca2+\u2212induced aggregation and fusion of complex liposomes","volume":"272","author":"Blackwood","year":"1997","journal-title":"Am J Phys"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/ncomms1037","article-title":"PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin ca(2+) release channels in the endolysosome","volume":"1","author":"Dong","year":"2010","journal-title":"Nat Commun"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"16242","DOI":"10.1074\/jbc.M002077200","article-title":"Novel function of phosphoinositide 3-kinase in T cell Ca2+ signaling. A phosphatidylinositol 3,4,5-trisphosphate-mediated Ca2+ entry mechanism","volume":"275","author":"Hsu","year":"2000","journal-title":"J Biol Chem"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/46587","article-title":"CtBP\/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid","volume":"402","author":"Weigert","year":"1999","journal-title":"Nature"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1021\/acs.jpcb.1c05337","article-title":"Structural dynamics and catalytic mechanism of ATP13A2 (PARK9) from simulations","volume":"125","author":"Mateeva","year":"2021","journal-title":"J Phys Chem B"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1038\/s41467-023-37741-0","article-title":"Conformational cycle of human polyamine transporter ATP13A2","volume":"14","author":"Mu","year":"2023","journal-title":"Nat Commun"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1016\/j.molcel.2021.08.017","article-title":"Structural basis of polyamine transport by human ATP13A2 (PARK9)","volume":"81","author":"Sim","year":"2021","journal-title":"Mol Cell"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1016\/j.molcel.2021.10.002","article-title":"Structural mechanisms for gating and ion selectivity of the human polyamine transporter ATP13A2","volume":"81","author":"Tillinghast","year":"2021","journal-title":"Mol Cell"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1096\/fj.09-135889","article-title":"Caenorhabditis elegans P5B-type ATPase CATP-5 operates in polyamine transport and is crucial for norspermidine-mediated suppression of RNA interference","volume":"24","author":"Heinick","year":"2010","journal-title":"FASEB J"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","article-title":"ATP13A2 deficiency disrupts lysosomal polyamine export","volume":"578","author":"van Veen","year":"2020","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0304-3940(01)01776-1","article-title":"Polyamines in the basal ganglia of human brain. Influence of aging and degenerative movement disorders","volume":"304","author":"Viv\u00f3","year":"2001","journal-title":"Neurosci Lett"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"16970","DOI":"10.1073\/pnas.1011751107","article-title":"Polyamine pathway contributes to the pathogenesis of Parkinson disease","volume":"107","author":"Lewandowski","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuint.2012.01.002","article-title":"CHO cells expressing the human P\u2085-ATPase ATP13A2 are more sensitive to the toxic effects of herbicide paraquat","volume":"60","author":"Pinto","year":"2012","journal-title":"Neurochem Int"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1042\/BJ20120739","article-title":"Parkinson\u2019s disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake","volume":"450","author":"De La Hera","year":"2013","journal-title":"Biochem J"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-37815-z","article-title":"Parkinson\u2019s disease-associated ATP13A2\/PARK9 functions as a lysosomal H+,K+-ATPase","volume":"14","author":"Fujii","year":"2023","journal-title":"Nat Commun"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/biom13020337","article-title":"Novel green fluorescent polyamines to analyze ATP13A2 and ATP13A3 activity in the mammalian polyamine transport system","volume":"13","author":"Houdou","year":"2023","journal-title":"Biomol Ther"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1038\/s41467-021-24148-y","article-title":"Structure and transport mechanism of P5B-ATPases","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"F1000 Faculty Rev-366","DOI":"10.12688\/f1000research.7431.1","article-title":"Metals and neurodegeneration","volume":"5","author":"Chen","year":"2016","journal-title":"F1000Res"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.neuro.2008.04.022","article-title":"Manganese transport in eukaryotes: the role of DMT1","volume":"29","author":"Au","year":"2008","journal-title":"Neurotoxicology"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnagi.2013.00023","article-title":"Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates","volume":"5","author":"Guilarte","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.3390\/ijerph120707519","article-title":"Manganese-induced parkinsonism and Parkinson\u2019s disease: shared and distinguishable features","volume":"12","author":"Kwakye","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuro.2012.01.007","article-title":"ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese","volume":"33","author":"Rentschler","year":"2012","journal-title":"Neurotoxicology"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ajhg.2012.01.018","article-title":"Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man","volume":"90","author":"Tuschl","year":"2012","journal-title":"Am J Hum Genet"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-94-007-5561-1_6","article-title":"Manganese homeostasis and transport","volume":"12","author":"Roth","year":"2013","journal-title":"Met Ions Life Sci"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jnr.10207","article-title":"Effect of the iron chelator desferrioxamine on manganese-induced toxicity of rat pheochromocytoma (PC12) cells","volume":"68","author":"Roth","year":"2002","journal-title":"J Neurosci Res"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0161-813x(01)00077-8","article-title":"Mechanisms of manganese-induced rat pheochromocytoma (PC12) cell death and cell differentiation","volume":"23","author":"Roth","year":"2002","journal-title":"Neurotoxicology"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/antiox11010071","article-title":"Parkinson\u2019s disease and the metal-microbiome-gut-brain axis: A systems toxicology approach","volume":"11","author":"Forero-Rodr\u00edguez","year":"2021","journal-title":"Antioxidants"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1039\/c2mt00185c","article-title":"Cellular transport and homeostasis of essential and nonessential metals","volume":"4","author":"Martinez-Finley","year":"2012","journal-title":"Metallomics"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3390\/antiox11122467","article-title":"Association between heavy metal exposure and Parkinson\u2019s disease: A review of the mechanisms related to oxidative stress","volume":"11","author":"Pyatha","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0006-2952(03)00145-x","article-title":"Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese","volume":"66","author":"Roth","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.neuroscience.2004.06.055","article-title":"Distribution of divalent metal transporter-1 in the monkey basal ganglia","volume":"128","author":"Huang","year":"2004","journal-title":"Neuroscience"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.etap.2005.03.009","article-title":"Manganese accumulation in striatum of mice exposed to toxic doses is dependent upon a functional dopamine transporter","volume":"20","author":"Erikson","year":"2005","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/toxsci\/kfm095","article-title":"Manganese induces oxidative impairment in cultured rat astrocytes","volume":"98","author":"Milatovic","year":"2007","journal-title":"Toxicol Sci"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1007\/s12035-021-02341-w","article-title":"Defective mitochondrial dynamics underlie manganese-induced neurotoxicity","volume":"58","author":"Morcillo","year":"2021","journal-title":"Mol Neurobiol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e34178","DOI":"10.1371\/journal.pone.0034178","article-title":"The role of the Parkinson\u2019s disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast","volume":"7","author":"Chesi","year":"2012","journal-title":"PLoS One"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1039\/C4TX00127C","article-title":"Manganese-induced neurotoxicity: from C. elegans to humans","volume":"4","author":"Chen","year":"2015","journal-title":"Toxicol Res"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","article-title":"The effect of age on the non-haemin iron in the human brain","volume":"3","author":"Hallgren","year":"1958","journal-title":"J Neurochem"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/nbm.922","article-title":"High-field magnetic resonance imaging of brain iron: birth of a biomarker?","volume":"17","author":"Schenck","year":"2004","journal-title":"NMR Biomed"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(96)12719-1","article-title":"Autoradiography of transferrin receptors in the human brain","volume":"211","author":"Griffiths","year":"1996","journal-title":"Neurosci Lett"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/jnr.1256","article-title":"Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat","volume":"66","author":"Burdo","year":"2001","journal-title":"J Neurosci Res"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"ref96","article-title":"Neurodegeneration with brain Iron accumulation disorders overview","volume-title":"GeneReviews\u00ae","author":"Gregory","year":"1993"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/157015913804999469","article-title":"Genetics and pathophysiology of neurodegeneration with brain Iron accumulation (NBIA)","volume":"11","author":"Schneider","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.3390\/ijms23148035","article-title":"ATP13A2 declines zinc-induced accumulation of \u03b1-Synuclein in a Parkinson\u2019s disease model","volume":"23","author":"Gao","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J Neurochem"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1016\/j.ajpath.2016.08.006","article-title":"Lysosomal storage of subunit c of mitochondrial ATP Synthase in brain-specific Atp13a2-Deficient mice","volume":"186","author":"Sato","year":"2016","journal-title":"Am J Pathol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mcn.2018.05.009","article-title":"Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis","volume":"92","author":"Rayaprolu","year":"2018","journal-title":"Mol Cell Neurosci"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"105513","DOI":"10.1016\/j.nbd.2021.105513","article-title":"Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological \u03b1-synuclein spread in the prodromal preformed fibrils model in young mice","volume":"159","author":"Johnson","year":"2021","journal-title":"Neurobiol Dis"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0632-14.2015","article-title":"\u03b1-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal parkinsonism protein Atp13a2","volume":"35","author":"Kett","year":"2015","journal-title":"J Neurosci"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbr.2018.01.029","article-title":"Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein","volume":"343","author":"Dirr","year":"2018","journal-title":"Behav Brain Res"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/cns.12023","article-title":"ATP13A2 knockout does not affect the infarct size in mice with acute ischemic stroke","volume":"18","author":"Yu","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1843.e1","DOI":"10.1016\/j.neurobiolaging.2011.12.035","article-title":"ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome","volume":"33","author":"Gr\u00fcnewald","year":"2012","journal-title":"Neurobiol Aging"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.nbd.2011.12.015","article-title":"ATP13A2 regulates mitochondrial bioenergetics through macroautophagy","volume":"45","author":"Gusdon","year":"2012","journal-title":"Neurobiol Dis"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"9531917","DOI":"10.1155\/2016\/9531917","article-title":"Protection against mitochondrial and metal toxicity depends on functional lipid binding sites in ATP13A2","volume":"2016","author":"Martin","year":"2016","journal-title":"Parkinsons Dis"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neulet.2013.08.061","article-title":"Manganese induces mitochondrial dynamics impairment and apoptotic cell death: A study in human Gli36 cells","volume":"554","author":"Alaimo","year":"2013","journal-title":"Neuroscience Letters"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1039\/c7mt00244k","article-title":"Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson\u2019s disease brain","volume":"9","author":"Genoud","year":"2017","journal-title":"Metallomics"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"31198","DOI":"10.1073\/pnas.1922342117","article-title":"ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress","volume":"117","author":"Vrijsen","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1073\/pnas.1112368109","article-title":"Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration","volume":"109","author":"Dehay","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/hmg\/ddr606","article-title":"PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity","volume":"21","author":"Ramonet","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1093\/hmg\/dds206","article-title":"Identification of novel ATP13A2 interactors and their role in \u03b1-synuclein misfolding and toxicity","volume":"21","author":"Usenovic","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4161\/auto.20256","article-title":"Lysosomal dysfunction in neurodegeneration: the role of ATP13A2\/PARK9","volume":"8","author":"Usenovic","year":"2012","journal-title":"Autophagy"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","article-title":"Deficiency of ATP13A2 leads to lysosomal dysfunction, \u03b1-synuclein accumulation, and neurotoxicity","volume":"32","author":"Usenovic","year":"2012","journal-title":"J Neurosci"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nbd.2013.05.017","article-title":"Divergent \u03b1-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson\u2019s disease brains with Lewy body pathology compared to idiopathic cases","volume":"58","author":"Mamais","year":"2013","journal-title":"Neurobiol Dis"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12031-011-9696-y","article-title":"Clinical and pathological characteristics of LRRK2 G2019S patients with PD","volume":"47","author":"Poulopoulos","year":"2012","journal-title":"J Mol Neurosci"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41531-022-00367-y","article-title":"Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson\u2019s disease","volume":"8","author":"Tezuka","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/brain\/awx344","article-title":"Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers","volume":"141","author":"Zhao","year":"2018","journal-title":"Brain"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1252400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:18:31Z","timestamp":1704428311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1252400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":125,"alternative-id":["10.3389\/fneur.2023.1252400"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1252400","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"article-number":"1252400"}}